Effects of Glucocorticosteroids on Neutrophil Functions in Asthma
Author Information
Author(s): P. L. Paggiaro, L. Bancalari, D. Giannessi, W. Bernini, G. Lazzerini, R. Sicari, E. Bacci, F. L. Dente, B. Vagaggini, R. De Caterina
Primary Institution: 2nd Institute of Internal Medicine, Respiratory Pathophysiology, and CNR Institute of Clinical Physiology, Pisa, Italy
Hypothesis
Does treatment with systemic glucocorticosteroids modify neutrophil functions in asthmatic subjects during an acute exacerbation?
Conclusion
The study found that neutrophil activation plays a minor role in asthma, and treatment with glucocorticosteroids does not significantly modify most neutrophil functions.
Supporting Evidence
- Superoxide anion generation was significantly higher in asthmatics compared to normal subjects.
- Neutrophil chemotaxis showed a significant correlation with asthma severity.
- After treatment, chemokinesis significantly decreased in all subjects.
- Neutrophil functions did not change significantly after glucocorticosteroid treatment.
Takeaway
This study looked at how a medicine called glucocorticosteroids affects certain white blood cells in people with asthma. It found that while the medicine helps asthma symptoms, it doesn't change how these cells work very much.
Methodology
The study evaluated neutrophil functions in asthmatic subjects during an acute exacerbation and after treatment with systemic glucocorticosteroids, measuring various parameters including chemotaxis and superoxide generation.
Limitations
The study primarily focused on peripheral neutrophils, which may not fully represent airway neutrophils' behavior.
Participant Demographics
21 asthmatic subjects (7 male, 14 female) with a mean age of 42 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website